Radiotherapy-induced Hypopituitarism in Nasopharyngeal Carcinoma: the Tip of an Iceberg

Abstract

Background: Radiation-induced hypopituitarism is an important late complication of cranial radiotherapy in children and adults. The purpose of this cross-sectional study was to evaluate the effects of radiotherapy on pituitary function in adult nasopharyngeal carcinoma patients.

Methods: Pituitary function was evaluated in 30 patients after cranial radiotherapy for nasopharyngeal carcinoma. Somatotroph and corticotroph axes were assessed by insulin tolerance test while gonadotroph and thyroid axes were evaluated by basal pituitary and end organ hormone levels at 10–133 months after radiotherapy.

Results: At least one hormonal disorder was observed in 28 (93%) patients after radiotherapy. 26 (87%) patients had one or more anterior pituitary hormone deficiencies. The rates of pituitary hormone deficiencies were 77% for growth hormone, followed by adrenocorticotropic hormone (73%), thyroid-stimulating hormone (27%) and gonadotropins (7%). Hyperprolactinemia was present in 13 (43%) patients.

Conclusions: Radiation-induced hypopituitarism is more common than expected in patients with nasopharyngeal carcinoma.

Key words

nasopharyngeal carcinoma - hypopituitarism - radiotherapy - radiation-induced hypopituitarism - pituitary hormone deficiency

^* Current address: Kent Hospital, Division of Endocrinology and Metabolism, Izmir, Turkey

^# Current address: Mevlana University, Faculty of Medicine, Department of Biochemistry, Konya, Turkey

• References

• 1 Fernandez A, Brada M, Zabuliene L et al. Radiation-induced hypo-pituitarism. Endocr Relat Cancer 2009; 16: 733-772
• 2 Darzy KH. Radiation-induced hypopituitarism after cancer therapy: Who, how and when to test. Nat Clin Pract Endocrinol Metab 2009; 5: 88-99
• 3 Tomlinson JW, Holden N, Hills RK et al. Association between premature mortality and hypopituitarism. Lancet 2001; 357: 425-431
• 4 Sherlock M, Ayuk J, Tomlinson JW et al. Mortality in patients with pituitary disease. Endocr Rev 2010; 31: 301-342
• 5 Lam KSL, Tse VKC, Wang C et al. Effects of cranial irradiation on hypothalamic-pituitary function – a 5-year longitudinal-study in patients with nasopharyngeal carcinoma. Q J Med 1991; 78: 165-176
• 6 Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth-hormone deficiency. J Pediatr 1991; 118: 226-228
• 7 Littley MD, Shalet SM, Beardwell CG et al. Hypopituitarism following external radiotherapy for pituitary-tumors in adults. Q J Med 1989; 70: 145-160
• 8 Schmiegelow M, Lassen S, Poulsen HS et al. Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors. Horm Res 2000; 54: 53-59
• 9 Achermann JC, Brook CGD, Hindmarsh PC. The GH response to low-dose bolus growth hormone-releasing hormone (GHRH(1-29)NH2) is attenuated in patients with longstanding post-irradiation GH insufficiency. Eur J Endocrinol 2000; 142: 359-364
• 10 Darzy KH, Aimaretti G, Wieringa G et al. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab 2003; 88: 95-102
• 11 Chan JKC, Bray F, McCarron P et al. Nasopharyngeal carcinoma. In: Barnes LEJ, Reichart P, Sidransky D. (eds.) World Health Organizaton classification of tumours pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005: 85-97
• 12 Lam KSL, Ho JHC, Lee AWM et al. Symptomatic hypothalamic-pituitary dysfunction in nasopharyngeal carcinoma patients following radiation-therapy – a retrospective study. Int J Radiat Oncol Biol Phys 1987; 13: 1343-1350
• 13 Siala W, Mnejja W, Abid M et al. Thyroid toxicity after radiotherapy of nasopharyngeal carcinoma. Ann Endocrinol (Paris) 2011; 72: 19-23
• 14 Wu YH, Wang HM, Chen HHW et al. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients. Int J Radiat Oncol Biol Phys 2010; 76: 1133-1139
• 15 Woo E, Lam K, Yu YL et al. Temporal-lobe and hypothalamic-pituitary dysfunctions after radiotherapy for nasopharyngeal carcinoma – a distinct clinical syndrome. J Neurol Neurosurg Psychiatry 1988; 51: 1302-1307
• 16 Chan JKC, Pilch BZ, Kuo TT et al. Tumours of the nasopharynx. In: Barnes LEJ, Reichart P, Sidransky D. (eds.) World Health Organizaton classification of tumours pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005: 81-84
• 17 Samaan NA, Schultz PN, Yang KPP et al. Endocrine complications after radiotherapy for tumors of the head and neck. J Lab Clin Med 1987; 109: 364-372
• 18 Huang TS, Lui LT, Hsu MM et al. Effect of cranial irradiation on hypothalamus-pituitary function: Follow-up study one year after radiotherapy. J Formos Med Assoc 1991; 90: 652-658
• 19 Pai HH, Thornton A, Katznelson L et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: Demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2001; 49: 1079-1092
• 20 Samaan NA, Vieto R, Schultz PN et al. Hypothalamic, pituitary and thyroid-dysfunction after radiotherapy to the head and neck. Int J Radiat Oncol Biol Phys 1982; 8: 1857-1867
• 21 Lam KSL, Tse VKC, Wang C et al. Early effects of cranial irradiation on hypothalamic-pituitary function. J Clin Endocrinol Metab 1987; 64: 418-424
• 22 Toogood AA. Endocrine consequences of brain irradiation. Growth Horm IGF Res 2004; 14: S118-S124
• 23 Abernethy AP, Shelby-James T, Fazekas BS et al. The Australia-modified Karnofsky Performance Status (AKPS) scale: A revised scale for contemporary palliative care clinical practice. BMC Palliat Care 2005; 4: 1-12
• 24 Agha A, Sherlock M, Brennan S et al. Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 2005; 90: 6355-6360
• 25 Bhandare N, Kennedy L, Malyapa RS et al. Hypopituitarism after radiotherapy for extracranial head and neck cancers. Head Neck 2008; 30: 1182-1192
• 26 Snyers A, Janssens G, Twickler MB et al. Malignant tumors of the nasal cavity and paranasal sinuses: Long-term outcome and morbidity with emphasis on hypothalamic-pituitary deficiency. Int J Radiat Oncol Biol Phys 2009; 73: 1343-1351
• 27 Zamboni C, Olmi P, Cellai E et al. Endocrine status in 29 patients treated by curative radiation-therapy for nasopharyngeal carcinoma. Tumori 1991; 77: 44-48
• 28 Lee AWM, Ng WT, Hung WM et al. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Int J Radiat Oncol Biol Phys 2009; 73: 1121-1128
• 29 Mercado G, Adelstein DJ, Saxton JP et al. Hypothyroidism – a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer 2001; 92: 2892-2897
• 30 Smolarz K, Malke G, Voth E et al. Hypothyroidism after therapy for larynx and pharynx carcinoma. Thyroid 2000; 10: 425-429
• 31 Sinard RJ, Tobin EJ, Mazzaferri EL et al. Hypothyroidism after treatment for nonthyroid head and neck cancer. Arch Otolaryngol Head Neck Surg 2000; 126: 652-657
• 32 Miller MC, Agrawal A. Hypothyroidism in postradiation head and neck cancer patients: Incidence, complications, and management. Curr Opin Otolaryngol Head Neck Surg 2009; 17: 111-115
• 33 Colevas AD, Read R, Thornhill J et al. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 2001; 51: 599-604
• 34 Arlt W, Hove U, Muller B et al. Frequent and frequently overlooked: Treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors. Neurology 1997; 49: 498-506
• 35 Nasrallah MP, Arafah BM. The value of dehydroepiandrosterone sulfate measurements in the assessment of adrenal function. J Clin Endocrinol Metab 2003; 88: 5293-5298
• 36 Rose SR, Lustig RH, Pitukcheewanont P et al. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 1999; 84: 4472-4479
• 37 Rose SR. Disorders of thyrotropin synthesis, secretion, and function. Curr Opin Pediatr 2000; 12: 375-381
• 38 Darzy KH, Shalet SM. Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors. J Clin Endocrinol Metab 2005; 90: 6490-6497
• 39 Huang TS, Huang SC, Hsu MM. A prospective-study of hypothalamus pituitary-function after cranial irradiation with or without radiosensitizing chemotherapy. J Endocrinol Invest 1994; 17: 615-623
• 40 Lee N, Harris J, Garden AS et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009; 27: 3684-3690
• 41 Sham J, Choy D, Kwong PWK et al. Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio. Int J Radiat Oncol Biol Phys 1994; 29: 699-704
• 42 Bates AS, Van’t Hoff W, Jones PJ et al. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996; 81: 1169-1172